Essential Updates in Ischemic Stroke Imaging and Treatment (2024)-T8-CNR09-2024

Video Transcription

Video Summary

In recent discussions about ischemic stroke treatment and evolving strategies, several studies and trials were highlighted to address gaps identified in past approaches, especially concerning large core patients and endovascular treatments. Traditional treatment guidelines which relied on factors like imaging techniques and core volume have expanded due in part to pivotal trials such as Resilient Extend and MR Clean Late. These trials highlighted both benefits and risks in extending time windows and utilizing simpler imaging methods. Despite promising outcomes for patients with moderate core sizes, especially with endovascular therapy, the trials exposed limitations, notably in accurately assessing ultra-large core patients.<br /><br />Aspects scoring, often employed in radiological evaluations, lacks consistent reliability across all patient categories. There is a pressing need for enhanced imaging criteria to define core size accurately and ensure better treatment selection and outcomes. Upcoming trials aim to integrate advanced imaging techniques more robustly to identify patient suitability for therapies. Meanwhile, the implications for neuroimaging are expanding, focusing on outcome prognostication and facilitating MIWU detection to streamline patient management and improve response times. By addressing imaging and treatment pathways, these efforts strive for better prognostic tools, ultimately optimizing care for ischemic stroke sufferers.

Keywords

ischemic stroke

endovascular treatment

large core patients

imaging techniques

Resilient Extend

MR Clean Late

Aspects scoring

neuroimaging

treatment pathways